Sign in
4

Changes in Ownership

Xilio Therapeutics, Inc. Filed Acc 0001415889-24-000305

Options or other derivatives

  • CHIEF OPERATING OFFICER acquired 77,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Frankenfield Christopher James CHIEF OPERATING OFFICER 2024-01-01 Grant or award · Restricted Stock Units +77,500 77,500 D
Loading xslF345X05/form4-01032024_090105.xml…